The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Epidemiological Pathology of Dementia: Attributable-Risks at Death in the Medical Research Council Cognitive Function and Ageing Study
Open accessAbstract
BACKGROUND: Dementia drug development aims to modulate pathological processes that cause clinical syndromes. Population data (epidemiological neuropathology) will help to model and predict the potential impact of such therapies on dementia burden in older people. Presently this can only be explored through post mortem findings. We report the attributable risks (ARs) for dementia at death for common age-related degenerative and vascular pathologies, and other factors, in the MRC Cognitive Function and Ageing Study (MRC CFAS). METHODS AND FINDINGS: A multicentre, prospective, longitudinal study of older people in the UK was linked to a brain donation programme. Neuropathology of 456 consecutive brain donations assessed degenerative and vascular pathologies. Logistic regression modelling, with bootstrapping and sensitivity analyses, was used to estimate AR at death for dementia for specific pathologies and other factors. The main contributors to AR at death for dementia in MRC CFAS were age (18%), small brain (12%), neocortical neuritic plaques (8%) and neurofibrillary tangles (11%), small vessel disease (12%), multiple vascular pathologies (9%), and hippocampal atrophy (10%). Other significant factors include cerebral amyloid angiopathy (7%) and Lewy bodies (3%). CONCLUSIONS: Such AR estimates cannot be derived from the living population; rather they estimate the relative contribution of specific pathologies to dementia at death. We found that multiple pathologies determine the overall burden of dementia. The impact of therapy targeted to a specific pathology may be profound when the dementia is relatively "pure," but may be less impressive for the majority with mixed disease, and in terms of the population. These data justify a range of strategies, and combination therapies, to combat the degenerative and vascular determinants of cognitive decline and dementia. Please see later in the article for the Editors' Summary.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“However, vascular brain lesions lower the threshold of AD pathology required to induce dementia. 56,100-102”
From Vascular Cognitive Impairment (2017) · cites this paper as [102]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Although the specific importance of subcortical infarcts and interaction has not been confirmed, subsequent studies have established that infarcts are additive with Alzheimer disease pathology in lowering cognitive function17,57 and increasing the odds of dementia17,18,62,63 or clinical Alzheimer disease.61”
From Vascular Contributions to Cognitive Impairment and Dementia: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association (2011) · cites this paper as [63]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“both lead to cognitive decline and dementia”
From Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration (2013) · cites this paper as [6]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“On the other hand, the density of tau-positive NPs does correlate directly and statistically independently with some degree of cognitive impairment (105-107) (Fig. 2).”
From Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature (2012) · cites this paper as [107]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An Introduction to the Bootstrap
Efron, B., & Tibshirani, R. J. (1994) · doi:10.1201/9780429246593 · Cited by 40,500
An Introduction to the Bootstrap
Efron, B., & Tibshirani, R. J. (1993) · doi:10.1007/978-1-4899-4541-9 · Cited by 21,230
Mirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., Vogel, F. S., Hughes, J. P., Belle, G. V., Berg, L., et al. (1991) · Neurology · doi:10.1212/wnl.41.4.479 · Cited by 4,961
Terry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397
Multiple imputation after 18+ years
Rubin, D. B. (1996) · Journal of the American Statistical Association · doi:10.1080/01621459.1996.10476908 · Cited by 4,072
Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis
Kayed, R., Head, E., Thompson, J. L., McIntire, T. M., Milton, S. C., Cotman, C. W., & Glabe, C. G. (2003) · Science · doi:10.1126/science.1079469 · Cited by 4,064
McKeith, I. G., Galasko, D., Kosaka, K., Perry, E. K., Dickson, D. W., Hansen, L. A., Salmon, D. P., Lowe, J., Mirra, S. S., Byrne, E. J., et al. (1996) · Neurology · doi:10.1212/wnl.47.5.1113 · Cited by 3,960
Self-citationMultiple Imputation After 18+ Years
Rubin, D. B. (1996) · Journal of the American Statistical Association · doi:10.2307/2291635 · Cited by 2,686
Mixed brain pathologies account for most dementia cases in community-dwelling older persons
Schneider, J. A., Arvanitakis, Z., Bang, W., & Bennett, D. A. (2007) · Neurology · doi:10.1212/01.wnl.0000271090.28148.24 · Cited by 1,992
HYMAN, B. T., & TROJANOWSKI, J. Q. (1997) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199710000-00002 · Cited by 1,542
Cited by
Wardlaw, J. M., Smith, E. E., Biessels, G. J., Cordonnier, C., Fazekas, F., Frayne, R., Lindley, R. I., O'Brien, J. T., Barkhof, F., Benavente, O. R., et al. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70124-8 · Cited by 5,544
Self-citationGorelick, P. B., Scuteri, A., Black, S. E., DeCarli, C., Greenberg, S. M., Iadecola, C., Launer, L. J., Laurent, S., Lopez, O. L., Nyenhuis, D., et al. (2011) · Stroke · doi:10.1161/str.0b013e3182299496 · Cited by 3,811
Potential for primary prevention of Alzheimer's disease: an analysis of population-based data
Norton, S., Matthews, F. E., Barnes, D. E., Yaffe, K., & Brayne, C. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70136-x · Cited by 2,466
Self-citationBallard, C., Gauthier, S., Corbett, A., Brayne, C., Aarsland, D., & Jones, E. (2011) · The Lancet · doi:10.1016/s0140-6736(10)61349-9 · Cited by 2,336
Self-citationNelson, P. T., Alafuzoff, I., Bigio, E. H., Bouras, C., Braak, H., Cairns, N. J., Castellani, R. J., Crain, B. J., Davies, P., Tredici, K. D., et al. (2012) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31825018f7 · Cited by 2,050
Defeating Alzheimer's disease and other dementias: a priority for European science and society
Winblad, B., Amouyel, P., Andrieu, S., Ballard, C., Brayne, C., Brodaty, H., Cedazo-Minguez, A., Dubois, B., Edvardsson, D., Feldman, H., et al. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(16)00062-4 · Cited by 1,676
Self-citationReligious Orders Study and Rush Memory and Aging Project
Bennett, D. A., Buchman, A. S., Boyle, P. A., Barnes, L. L., Wilson, R. S., & Schneider, J. A. (2018) · Journal of Alzheimer's Disease · doi:10.3233/jad-179939 · Cited by 1,260
“This is consistent with the results of several prior clinical-pathologic studies that have examined this issue [4, 369–377].”
Arevalo-Rodriguez, I., Smailagic, N., Roqué i Figuls, M., Ciapponi, A., Sanchez-Perez, E., Giannakou, A., Pedraza, O. L., Bonfill Cosp, X., & Cullum, S. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010783.pub2 · Cited by 831
Creavin, S. T., Wisniewski, S., Noel-Storr, A. H., Trevelyan, C. M., Hampton, T., Rayment, D., Thom, V. M., Nash, K. J. E., Elhamoui, H., Milligan, R., et al. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011145.pub2 · Cited by 820
Frailty and cognitive impairment—A review of the evidence and causal mechanisms
Robertson, D. A., Savva, G. M., & Kenny, R. A. (2013) · Ageing Research Reviews · doi:10.1016/j.arr.2013.06.004 · Cited by 751
van Charante, E. P. M., Richard, E., Eurelings, L. S., van Dalen, J.-W., Ligthart, S. A., van Bussel, E. F., Hoevenaar-Blom, M. P., Vermeulen, M., & van Gool, W. A. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30950-3 · Cited by 611
Lewy- and Alzheimer-type pathologies in Parkinson's disease dementia: which is more important?
Compta, Y., Parkkinen, L., O'Sullivan, S. S., Vandrovcova, J., Holton, J. L., Collins, C., Lashley, T., Kallis, C., Williams, D. R., de Silva, R., et al. (2011) · Brain · doi:10.1093/brain/awr031 · Cited by 583
Dichgans, M., & Leys, D. (2017) · Circulation Research · doi:10.1161/circresaha.116.308426 · Cited by 581
Delirium is a strong risk factor for dementia in the oldest-old: a population-based cohort study
Davis, D. H. J., Muniz Terrera, G., Keage, H., Rahkonen, T., Oinas, M., Matthews, F. E., Cunningham, C., Polvikoski, T., Sulkava, R., MacLullich, A. M. J., et al. (2012) · Brain · doi:10.1093/brain/aws190 · Cited by 558
Self-citationArevalo-Rodriguez, I., Smailagic, N., Roqué-Figuls, M., Ciapponi, A., Sanchez-Perez, E., Giannakou, A., Pedraza, O. L., Bonfill Cosp, X., & Cullum, S. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010783.pub3 · Cited by 461
Cerebral microinfarcts: the invisible lesions
Smith, E. E., Schneider, J. A., Wardlaw, J. M., & Greenberg, S. M. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70307-6 · Cited by 456
Neuropathology underlying clinical variability in patients with synucleinopathies
Halliday, G. M., Holton, J. L., Revesz, T., & Dickson, D. W. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0852-9 · Cited by 430
Kalaria, R. N. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1571-z · Cited by 441
A clinicopathological approach to the diagnosis of dementia
Elahi, F. M., & Miller, B. L. (2017) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.96 · Cited by 412
Cerebral amyloid angiopathy and cognitive outcomes in community-based older persons
Boyle, P. A., Yu, L., Nag, S., Leurgans, S., Wilson, R. S., Bennett, D. A., & Schneider, J. A. (2015) · Neurology · doi:10.1212/wnl.0000000000002175 · Cited by 423
Education, the brain and dementia: neuroprotection or compensation?
Brayne, C., Ince, P. G., Keage, H. A. D., McKeith, I. G., Matthews, F. E., Polvikoski, T., & Sulkava, R. (2010) · Brain · doi:10.1093/brain/awq185 · Cited by 392
Self-citationA major role for cardiovascular burden in age-related cognitive decline
Qiu, C., & Fratiglioni, L. (2015) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2014.223 · Cited by 398
Integrated multimodal cell atlas of Alzheimer’s disease
Gabitto, M. I., Travaglini, K. J., Rachleff, V. M., Kaplan, E. S., Long, B., Ariza, J., Ding, Y., Mahoney, J. T., Dee, N., Goldy, J., et al. (2024) · Nature Neuroscience · doi:10.1038/s41593-024-01774-5 · Cited by 397
Cerebral amyloid angiopathy pathology and cognitive domains in older persons
Arvanitakis, Z., Leurgans, S. E., Wang, Z., Wilson, R. S., Bennett, D. A., & Schneider, J. A. (2011) · Annals of Neurology · doi:10.1002/ana.22112 · Cited by 383
Prevalence of mixed pathologies in the aging brain
Rahimi, J., & Kovacs, G. G. (2014) · Alzheimer's Research & Therapy · doi:10.1186/s13195-014-0082-1 · Cited by 364
Review: sporadic cerebral amyloid angiopathy
Attems, J., Jellinger, K., Thal, D. R., & Van Nostrand, W. (2011) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2010.01137.x · Cited by 371
The degree of frailty as a translational measure of health in aging
Howlett, S. E., Rutenberg, A. D., & Rockwood, K. (2021) · Nature Aging · doi:10.1038/s43587-021-00099-3 · Cited by 338
Preventing dementia by preventing stroke: The Berlin Manifesto
Hachinski, V., Einhäupl, K., Ganten, D., Alladi, S., Brayne, C., Stephan, B. C. M., Sweeney, M. D., Zlokovic, B., Iturria‐Medina, Y., Iadecola, C., et al. (2019) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2019.06.001 · Cited by 313
Self-citationAttributable risk of Alzheimer's dementia attributed to age-related neuropathologies
Boyle, P. A., Yu, L., Leurgans, S. E., Wilson, R. S., Brookmeyer, R., Schneider, J. A., & Bennett, D. A. (2019) · Annals of Neurology · doi:10.1002/ana.25380 · Cited by 318
Hainsworth, A. H., Markus, H. S., & Schneider, J. A. (2024) · Hypertension · doi:10.1161/hypertensionaha.123.19943 · Cited by 247
Cognitive impairment, decline and fluctuations in older community-dwelling subjects with Lewy bodies
Schneider, J. A., Arvanitakis, Z., Yu, L., Boyle, P. A., Leurgans, S. E., & Bennett, D. A. (2012) · Brain · doi:10.1093/brain/aws234 · Cited by 273
Wardlaw, J. M., Makin, S. J., Valdés Hernández, M. C., Armitage, P. A., Heye, A. K., Chappell, F. M., Muñoz‐Maniega, S., Sakka, E., Shuler, K., Dennis, M. S., et al. (2017) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.09.006 · Cited by 260
Mc Donald, J. M., Savva, G. M., Brayne, C., Welzel, A. T., Forster, G., Shankar, G. M., Selkoe, D. J., Ince, P. G., & Walsh, D. M. (2010) · Brain · doi:10.1093/brain/awq065 · Cited by 234
Self-citationClinical presentations and epidemiology of vascular dementia
Smith, E. E. (2017) · Clinical Science · doi:10.1042/cs20160607 · Cited by 249
Davis, D. H. J., Muniz-Terrera, G., Keage, H. A. D., Stephan, B. C. M., Fleming, J., Ince, P. G., Matthews, F. E., Cunningham, C., Ely, E. W., MacLullich, A. M. J., et al. (2017) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2016.3423 · Cited by 252
Self-citationCerebral hypoperfusion accelerates cerebral amyloid angiopathy and promotes cortical microinfarcts
Okamoto, Y., Yamamoto, T., Kalaria, R. N., Senzaki, H., Maki, T., Hase, Y., Kitamura, A., Washida, K., Yamada, M., Ito, H., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-011-0925-9 · Cited by 249
Mixed pathology is more likely in black than white decedents with Alzheimer dementia
Barnes, L. L., Leurgans, S., Aggarwal, N. T., Shah, R. C., Arvanitakis, Z., James, B. D., Buchman, A. S., Bennett, D. A., & Schneider, J. A. (2015) · Neurology · doi:10.1212/wnl.0000000000001834 · Cited by 236
Kalaria, R. N. (2012) · Stroke · doi:10.1161/strokeaha.112.655803 · Cited by 227
Garwood, C. J., Ratcliffe, L. E., Simpson, J. E., Heath, P. R., Ince, P. G., & Wharton, S. B. (2017) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12338 · Cited by 233
Self-citationThe Prevalence and Incidence of Dementia with Lewy Bodies: a Systematic Review
Hogan, D. B., Fiest, K. M., Roberts, J. I., Maxwell, C. J., Dykeman, J., Pringsheim, T., Steeves, T., Smith, E. E., Pearson, D., & Jetté, N. (2016) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/cjn.2016.2 · Cited by 220
Ritchie, C., Smailagic, N., Noel-Storr, A. H., Ukoumunne, O., Ladds, E. C., & Martin, S. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010803.pub2 · Cited by 208
Causes and Patterns of Dementia: An Update in the Era of Redefining Alzheimer's Disease
James, B. D., & Bennett, D. A. (2019) · Annual Review of Public Health · doi:10.1146/annurev-publhealth-040218-043758 · Cited by 199
White matter degeneration in vascular and other ageing‐related dementias
Hase, Y., Horsburgh, K., Ihara, M., & Kalaria, R. N. (2018) · Journal of Neurochemistry · doi:10.1111/jnc.14271 · Cited by 208
Cunningham, C., & Hennessy, E. (2015) · Alzheimer's Research & Therapy · doi:10.1186/s13195-015-0117-2 · Cited by 211
Simpson, J. E., Ince, P. G., Shaw, P. J., Heath, P. R., Raman, R., Garwood, C. J., Gelsthorpe, C., Baxter, L., Forster, G., Matthews, F. E., et al. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.04.013 · Cited by 192
Self-citationNeuropathological correlates of late-life depression in older people
Tsopelas, C., Stewart, R., Savva, G. M., Brayne, C., Ince, P., Thomas, A., & Matthews, F. E. (2011) · British Journal of Psychiatry · doi:10.1192/bjp.bp.110.078816 · Cited by 182
“18,21,25 The neuropathological assessment was a standardised assessment of paraffin-embedded tissues using the CERAD protocol.”
InfluentialSelf-citationChanging demography and the challenge of dementia in India
Ravindranath, V., & Sundarakumar, J. S. (2021) · Nature Reviews Neurology · doi:10.1038/s41582-021-00565-x · Cited by 172
Cognitive impairment and stroke in elderly patients
Corrao, S., Lo Coco, D., & Lopez, G. (2016) · Vascular Health and Risk Management · doi:10.2147/vhrm.s75306 · Cited by 158
Challenges of multimorbidity of the aging brain: a critical update
Jellinger, K. A., & Attems, J. (2015) · Journal of Neural Transmission · doi:10.1007/s00702-014-1288-x · Cited by 154
Suemoto, C. K., Ferretti‐Rebustini, R. E. D. L., Rodriguez, R. D., Leite, R. E. P., Soterio, L., Brucki, S. M. D., Spera, R. R., Cippiciani, T. M., Farfel, J. M., Filho, A. D. P. C., et al. (2017) · PLoS Medicine · doi:10.1371/journal.pmed.1002267 · Cited by 158
Ihl, R., Bachinskaya, N. Y., Korczyn, A. D., Vakhapova, V., Tribanek, M., Hoerr, R., & Napryeyenko, O. (2010) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.2662 · Cited by 148
Ding, R., Hase, Y., Ameen‐Ali, K. E., Ndung'u, M., Stevenson, W., Barsby, J., Gourlay, R., Akinyemi, T. O., Akinyemi, R., Uemura, M. T., et al. (2020) · Brain Pathology · doi:10.1111/bpa.12888 · Cited by 155
Cerebral Amyloid Angiopathy Is Associated With Executive Dysfunction and Mild Cognitive Impairment
Case, N. F., Charlton, A., Zwiers, A. M., Batool, S. A., McCreary, C. R., Hogan, D. B., Ismail, Z., Zerna, C., Coutts, S. B., Frayne, R., et al. (2016) · Stroke · doi:10.1161/strokeaha.116.012999 · Cited by 153
COVID-19 and Alzheimer’s disease: how one crisis worsens the other
Xia, X., Wang, Y., & Zheng, J. (2021) · Translational Neurodegeneration · doi:10.1186/s40035-021-00237-2 · Cited by 152
Vascular disease and dementias: Paradigm shifts to drive research in new directions
Kling, M. A., Trojanowski, J. Q., Wolk, D. A., Lee, V. M. ‐., & Arnold, S. E. (2012) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2012.02.007 · Cited by 150
Harrison, J. K., Fearon, P. A., Noel-Storr, A. H., McShane, R. H., Stott, D. J., & Quinn, T. J. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010772.pub2 · Cited by 149
Age-associated changes in the blood-brain barrier: comparative studies in human and mouse.
Goodall, E. F., Wang, C., Simpson, J. E., Baker, D. J., Drew, D. R., Heath, P. R., Saffrey, M. J., Romero, I. A., & Wharton, S. B. (2018) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12408 · Cited by 120
Self-citationKhan, A., Kalaria, R. N., Corbett, A., & Ballard, C. G. (2016) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988716654987 · Cited by 145
Epidemiological Neuropathology: The MRC Cognitive Function and Aging Study Experience
Wharton, S. B., Brayne, C., Savva, G. M., Matthews, F. E., Forster, G., Simpson, J. E., Lace, G., & Ince, P. G. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-091402 · Cited by 146
Self-citationIhl, R., Tribanek, M., Bachinskaya, N. Y., & for the GOTADAY Study Group (2011) · Pharmacopsychiatry · doi:10.1055/s-0031-1291217 · Cited by 128
Murray, A. D., Staff, R. T., McNeil, C. J., Salarirad, S., Ahearn, T. S., Mustafa, N., & Whalley, L. J. (2011) · Brain · doi:10.1093/brain/awr259 · Cited by 141
Serrano‐Pozo, A., Qian, J., Muzikansky, A., Monsell, S. E., Montine, T. J., Frosch, M. P., Betensky, R. A., & Hyman, B. T. (2016) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlw026 · Cited by 120
Davis, D. H. J., Creavin, S., Noel-Storr, A., Quinn, T. J., Smailagic, N., Hyde, C., Brayne, C., McShane, R. H., & Cullum, S. J. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010460 · Cited by 112
Self-citationNichols, E., Merrick, R., Hay, S. I., Himali, D., Himali, J. J., Hunter, S., Keage, H. A. D., Latimer, C. S., Scott, M. R., Steinmetz, J. D., et al. (2023) · The Lancet Healthy Longevity · doi:10.1016/s2666-7568(23)00019-3 · Cited by 108
Self-citationSerrano‐Pozo, A., Qian, J., Monsell, S. E., Frosch, M. P., Betensky, R. A., & Hyman, B. T. (2013) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0000000000000016 · Cited by 114
Age‐Associated White Matter Lesions: The MRC C ognitive F unction and A geing S tudy
Wharton, S. B., Simpson, J. E., Brayne, C., & Ince, P. G. (2014) · Brain Pathology · doi:10.1111/bpa.12219 · Cited by 117
Self-citationDementia in Patients Hospitalized with Stroke: Rates, Time Course, and Clinico-Pathologic Factors
Pendlebury, S. T. (2012) · International Journal of Stroke · doi:10.1111/j.1747-4949.2012.00837.x · Cited by 115
White matter capillaries in vascular and neurodegenerative dementias
Hase, Y., Ding, R., Harrison, G., Hawthorne, E., King, A., Gettings, S., Platten, C., Stevenson, W., Craggs, L. J. L., & Kalaria, R. N. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0666-x · Cited by 101
Multiple Biological Pathways Link Cognitive Lifestyle to Protection from Dementia
Valenzuela, M. J., Matthews, F. E., Brayne, C., Ince, P., Halliday, G., Kril, J. J., Dalton, M. A., Richardson, K., Forster, G., & Sachdev, P. S. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.07.036 · Cited by 100
Self-citationThal, D. R., Attems, J., & Ewers, M. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-141461 · Cited by 100
Ligthart, S. A., Richard, E., van Charante, M., & van Gool, W. A. (2010) · Vascular Health and Risk Management · doi:10.2147/vhrm.s7343 · Cited by 113
Varma, V. R., Wang, Y., An, Y., Varma, S., Bilgel, M., Doshi, J., Legido-Quigley, C., Delgado, J. C., Oommen, A. M., Roberts, J. A., et al. (2021) · PLOS Medicine · doi:10.1371/journal.pmed.1003615 · Cited by 97
“It is also important to note that large longitudinal studies have consistently reported that mixed brain pathologies account for the majority of dementia cases with considerable overlap between AD neuropathology and vascular brain injury including macroscopic, lacunar, and microscopic infarcts [51,52].”
Lesions without symptoms: understanding resilience to Alzheimer disease neuropathological changes
Gómez-Isla, T., & Frosch, M. P. (2022) · Nature Reviews Neurology · doi:10.1038/s41582-022-00642-9 · Cited by 96
Viggars, A. P., Wharton, S. B., Simpson, J. E., Matthews, F. E., Brayne, C., Savva, G. M., Garwood, C. J., Drew, D., Shaw, P. J., & Ince, P. G. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.09.049 · Cited by 99
Self-citationNeuropathology of White Matter Lesions, Blood–Brain Barrier Dysfunction, and Dementia
Hainsworth, A. H., Minett, T., Andoh, J., Forster, G., Bhide, I., Barrick, T. R., Elderfield, K., Jeevahan, J., Markus, H. S., & Bridges, L. (2017) · Stroke · doi:10.1161/strokeaha.117.018101 · Cited by 106
Brayne, C., & Moffitt, T. E. (2022) · Nature Aging · doi:10.1038/s43587-022-00277-x · Cited by 89
Self-citationJanaway, B. M., Simpson, J. E., Hoggard, N., Highley, J. R., Forster, G., Drew, D., Gebril, O. H., Matthews, F. E., Brayne, C., Wharton, S. B., et al. (2013) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12062 · Cited by 91
Self-citationOxidative Glial Cell Damage Associated with White Matter Lesions in the Aging Human Brain
Al‐Mashhadi, S., Simpson, J. E., Heath, P. R., Dickman, M., Forster, G., Matthews, F. E., Brayne, C., Ince, P. G., Wharton, S. B., & Medical Research Council Cognitive Function and Ageing Study (2015) · Brain Pathology · doi:10.1111/bpa.12216 · Cited by 85
Self-citationHealth economic evaluation of treatments for Alzheimer′s disease: impact of new diagnostic criteria
Wimo, A. B., Ballard, C. G., Brayne, C., Gauthier, S. G., Handels, R. L. H., Jones, R. W., Jönsson, L., Khachaturian, A. S., & Kramberger, M. G. (2014) · Journal of Internal Medicine · doi:10.1111/joim.12167 · Cited by 89
Self-citationMuzambi, R., Bhaskaran, K., Smeeth, L., Brayne, C., Chaturvedi, N., & Warren-Gash, C. (2021) · The Lancet Healthy Longevity · doi:10.1016/s2666-7568(21)00118-5 · Cited by 84
Self-citationCollaborators, G. 2. D. (2021) · Neuroepidemiology · doi:10.1159/000515393 · Cited by 83
Clinicopathological Outcomes of Prospectively Followed Normal Elderly Brain Bank Volunteers
Dugger, B. N., Hentz, J. G., Adler, C. H., Sabbagh, M. N., Shill, H. A., Jacobson, S. A., Caviness, J. N., Belden, C. M., Driver‐Dunckley, E. D., Davis, K. J., et al. (2014) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0000000000000046 · Cited by 86
Quinn, T. J., Gallacher, J., Deary, I. J., Lowe, G. D. O., Fenton, C., & Stott, D. J. (2011) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2011.04403.x · Cited by 90
Yamada, M., Ihara, M., Okamoto, Y., Maki, T., Washida, K., Kitamura, A., Hase, Y., Ito, H., Takao, K., Miyakawa, T., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016567 · Cited by 89
Stage-Specific Changes in Neurogenic and Glial Markers in Alzheimer’s Disease
Ekonomou, A., Savva, G. M., Brayne, C., Forster, G., Francis, P. T., Johnson, M. A., Perry, E. K., Attems, J., Somani, A., Minger, S. L., et al. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.05.021 · Cited by 87
Self-citationChen, X., Liu, X., Koundal, S., Elkin, R., Zhu, X. A., Monte, B., Xu, F., Dai, F., Pedram, M., Lee, H., et al. (2022) · Nature Aging · doi:10.1038/s43587-022-00181-4 · Cited by 89
Wennberg, A. M., Whitwell, J. L., Tosakulwong, N., Weigand, S. D., Murray, M. E., Machulda, M. M., Petrucelli, L., Mielke, M. M., Jack, C. R., Knopman, D. S., et al. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.01.008 · Cited by 79
Lecanemab for Alzheimer’s disease
Walsh, S., Merrick, R., Richard, E., Nurock, S., & Brayne, C. (2022) · BMJ · doi:10.1136/bmj.o3010 · Cited by 76
Self-citationYang, Z., Slavin, M. J., & Sachdev, P. S. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2013.105 · Cited by 82
Lewandowski, C. T., Maldonado Weng, J., & LaDu, M. J. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.104811 · Cited by 72
What do we mean by Alzheimer's disease?
Richards, M., & Brayne, C. (2010) · BMJ · doi:10.1136/bmj.c4670 · Cited by 73
Self-citationvon Gunten, A., Schlaefke, S., & Überla, K. (2015) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2015.1066513 · Cited by 77
Prevalence of dementia subtypes in a developing country: a clinicopathological study
Grinberg, L. T., Nitríni, R., Suemoto, C. K., Ferretti‐Rebustini, R. E. D. L., Leite, R. E. P., Farfel, J. M., Santos, E. B., Andrade, M. P., Alho, A. T. D. L., Lima, M. D. C., et al. (2013) · Clinics · doi:10.6061/clinics/2013(08)13 · Cited by 72
The Blackfriars consensus on brain health and dementia
Lincoln, P., Fenton, K., Alessi, C., Prince, M., Brayne, C., Wortmann, M., Patel, K., Deanfield, J., & Mwatsama, M. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60758-3 · Cited by 69
Self-citationAttenuated CSF‐1R signalling drives cerebrovascular pathology
Delaney, C. P., Farrell, M., Doherty, C. P., Brennan, K., O’Keeffe, E., Greene, C., Byrne, K., Kelly, E., Birmingham, N., Hickey, P. P., et al. (2020) · EMBO Molecular Medicine · doi:10.15252/emmm.202012889 · Cited by 79
What would a population‐level approach to dementia risk reduction look like, and how would it work?
Walsh, S., Govia, I., Peters, R., Richard, E., Stephan, B. C. M., Wilson, N., Wallace, L. M. K., Anstey, K. J., & Brayne, C. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.12985 · Cited by 73
Self-citationStacked binding of a PET ligand to Alzheimer’s tau paired helical filaments
Merz, G. E., Chalkley, M. J., Tan, S. K., Tse, E., Lee, J., Prusiner, S. B., Paras, N. A., DeGrado, W. F., & Southworth, D. R. (2023) · Nature Communications · doi:10.1038/s41467-023-38537-y · Cited by 71
Gkanatsiou, E., Portelius, E., Toomey, C. E., Blennow, K., Zetterberg, H., Lashley, T., & Brinkmalm, G. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.02.033 · Cited by 72
African ancestry protects against Alzheimer's disease-related neuropathology
the Brazilian Aging Brain Study Group, Schlesinger, D., Grinberg, L. T., Alba, J. G., Naslavsky, M. S., Licínio, L., Farfel, J. M., Suemoto, C. K., Ferretti‐Rebustini, R. E. D. L., Leite, R. E. P., et al. (2011) · Molecular Psychiatry · doi:10.1038/mp.2011.136 · Cited by 67
Quantitative gait, cognitive decline, and incident dementia: The Rotterdam Study
Darweesh, S. K. L., Licher, S., Wolters, F. J., Koudstaal, P. J., Ikram, M. K., & Ikram, M. A. (2019) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2019.03.013 · Cited by 70
Metadata
- Authors
- Matthews, F. E., Brayne, C., Lowe, J., McKeith, I., Wharton, S. B., & Ince, P.
- Affiliations
- University of Cambridge (GB)
- University of Nottingham (GB)
- Newcastle University (GB)
- University of Sheffield (GB)
- Corresponding author
- Ince, Paul
- Venue
- PLoS Medicine
- Publisher
- Public Library of Science (PLoS)
- Published
- 2009-11-10
- Volume
- 6
- Issue
- 11
- Pages
- e1000180
- ISSN
- 1549-1277 (ISSN-L)
- 1549-1676
- PMC
- PMC2765638
- OpenAlex
- W2039937642
- Cited by
- 279
- References
- 40
- Citations by year
- 2026: 5 · 2025: 4 · 2024: 8 · 2023: 12 · 2022: 15 · 2021: 19 · 2020: 20 · 2019: 23 · 2018: 15 · 2017: 23 · 2016: 28 · 2015: 10 · 2014: 20 · 2013: 19 · 2012: 20
- FWCI
- 11.51
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS Medicine (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Repository@Hull (Worktribe) (University of Hull) (submittedVersion, cc-by)
- Newcastle University ePrints (Newcastle Univesity)
- Funders
- Medical Research Council (G9901400)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Keywords
- dementia, neuropathology, attributable risk, vascular pathology, cerebral small vessel disease, cerebral amyloid angiopathy, Lewy bodies, neurofibrillary tangles, hippocampal atrophy, brain donation, MRC Cognitive Function and Ageing Study, dementia burden, combination therapy
- MeSH terms
- Age Factors, Aged, Aged, 80 and over, Aging, Brain, Death, Dementia, Female, United Kingdom, Humans, Longitudinal Studies, Male, Organ Size, Prospective Studies, Risk Factors, Sensitivity and Specificity, Vascular Diseases, Logistic Models, Lewy Bodies, Cerebral Amyloid Angiopathy, Neurofibrillary Tangles
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.

